The clinical effect of glucose meter selection upon the detection of neonatal hypoglycemia

Area of Science:

• Neonatal Medicine
• Clinical Chemistry
• Medical Technology

Background:

• Neonatal hypoglycemia is a frequent transitional metabolic issue with potential neurodevelopmental consequences.
• Clinical practice guidelines often recommend glucose point-of-care testing (POCT) for screening and diagnosis.
• The widespread adoption of POCT in Neonatal Intensive Care Units (NICUs) presents challenges.

Purpose of the Study:

• To highlight the critical implications of current glucose POCT practices in neonatal care.
• To address the limitations of POCT devices in accurately detecting neonatal hypoglycemia.
• To emphasize the need for improved standardization and collaboration for neonatal glucose monitoring.

Main Methods:

• Review of current clinical practice guidelines for neonatal hypoglycemia management.
• Analysis of the limitations and consequences of glucose point-of-care testing (POCT) in the NICU.
• Discussion of the need for traceability and standardization of POCT devices.

Main Results:

• POCT devices often lack international traceability to gold-standard glucose methods.
• There is an under-recognition of POCT limitations in the context of neonatal hypoglycemia.
• Current POCT technology is primarily designed for adult hyperglycemia, not neonatal hypoglycemia.

Conclusions:

• Robust communication between healthcare providers and clinical laboratories is essential.
• Selection, standardization, and interpretation of glucose POCT require careful consideration.
• Optimizing neonatal glucose detection necessitates addressing POCT limitations and ensuring accurate monitoring.